Sign up to save your podcasts
Or
Share Motif Neurotech Gets FDA IDE To Study Brain Implant In Depression
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Motif Neurotech Gets FDA IDE To Study Brain Implant In Depression
Motif Neurotech’s implantable depression device may expand treatment options through minimally invasive brain stimulation, offering personalized at-home therapy for patients with treatment-resistant depression.
View all episodes
By TheBrief.HealthMotif Neurotech’s implantable depression device may expand treatment options through minimally invasive brain stimulation, offering personalized at-home therapy for patients with treatment-resistant depression.